← Back to Search

Other

Creatine Monohydrate for Depression

Phase 4
Waitlist Available
Led By Perry F Renshaw, MD, PhD, MBA
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

This trial will test whether a dietary supplement can help reduce the severity of depression in people with type 2 diabetes.

Eligible Conditions
  • Depression

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from Baseline in Hamilton Depression Rating Scale

Trial Design

1Treatment groups
Experimental Treatment
Group I: Open Label Treatment with CreatineExperimental Treatment1 Intervention
5 grams daily of oral creatine monohydrate powde
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Creatine
FDA approved

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,099 Previous Clinical Trials
1,778,707 Total Patients Enrolled
23 Trials studying Depression
2,402 Patients Enrolled for Depression
Perry F Renshaw, MD, PhD, MBAPrincipal InvestigatorUniversity of Utah
3 Previous Clinical Trials
175 Total Patients Enrolled
2 Trials studying Depression
71 Patients Enrolled for Depression

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby Apr 2025